speb/financial-data huggingface dataset:
PET.AX balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 2000.00
PET.AX balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 2000.00
PET.AX balance_sheet (annual, 2022-12-31) — Current Liabilities: 2805000.00
PET.AX income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 70000.00
PET.AX income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 70000.00
PET.AX income_statement (annual, 2022-12-31) — Depreciation Income Statement: 63000.00
PET.AX income_statement (annual, 2022-12-31) — Diluted Average Shares: 624390509.00
PET.AX income_statement (annual, 2022-12-31) — Diluted EPS: -0.02
PET.AX income_statement (annual, 2022-12-31) — EBIT: -10758000.00
PET.AX income_statement (annual, 2022-12-31) — EBITDA: -10688000.00
PET.AX cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -150000.00
PET.AX balance_sheet (annual, 2022-12-31) — Employee Benefits: 19000.00
PET.AX cash_flow (annual, 2022-12-31) — End Cash Position: 14456000.00
PET.AX cash_flow (annual, 2022-12-31) — Financing Cash Flow: -687000.00
PET.AX balance_sheet (annual, 2022-12-31) — Finished Goods: 3692000.00
PET.AX balance_sheet (annual, 2022-12-31) — Foreign Currency Translation Adjustments: 1128000.00
PET.AX cash_flow (annual, 2022-12-31) — Free Cash Flow: -7698000.00
PET.AX balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 1128000.00
PET.AX income_statement (annual, 2022-12-31) — General And Administrative Expense: 5818000.00
PET.AX income_statement (annual, 2022-12-31) — Gross Profit: 696000.00
PET.AX income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 1513000.00
PET.AX cash_flow (annual, 2022-12-31) — Interest Received Direct: 84000.00
PET.AX balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -2145000.00
PET.AX balance_sheet (annual, 2022-12-31) — Inventory: 2420000.00
PET.AX balance_sheet (annual, 2022-12-31) — Invested Capital: 14641000.00
PET.AX cash_flow (annual, 2022-12-31) — Investing Cash Flow: -628000.00
PET.AX balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 464000.00
PET.AX balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 464000.00
PET.AX balance_sheet (annual, 2022-12-31) — Long Term Provisions: 188000.00
PET.AX income_statement (annual, 2022-12-31) — Net Income: -11212000.00
PET.AX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -11212000.00
PET.AX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -11212000.00
PET.AX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -11212000.00
PET.AX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -11212000.00
PET.AX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -11212000.00
PET.AX cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -83000.00
PET.AX income_statement (annual, 2022-12-31) — Net Interest Income: -10000.00
PET.AX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -10000.00
PET.AX cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -687000.00
PET.AX cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -545000.00
PET.AX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 14641000.00
PET.AX balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 19000.00
PET.AX income_statement (annual, 2022-12-31) — Normalized EBITDA: -9175000.00
PET.AX income_statement (annual, 2022-12-31) — Normalized Income: -9699000.00
PET.AX income_statement (annual, 2022-12-31) — Operating Income: -10758000.00
PET.AX income_statement (annual, 2022-12-31) — Operating Revenue: 3022000.00
PET.AX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 624390509.00
PET.AX cash_flow (annual, 2022-12-31) — Other Cash Receiptsfrom Operating Activities: 798000.00
PET.AX balance_sheet (annual, 2022-12-31) — Other Current Assets: 144000.00
PET.AX income_statement (annual, 2022-12-31) — Other Gand A: 5486000.00
PET.AX income_statement (annual, 2022-12-31) — Other Income Expense: -514000.00
PET.AX income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 999000.00
PET.AX income_statement (annual, 2022-12-31) — Other Operating Expenses: 5302000.00
PET.AX balance_sheet (annual, 2022-12-31) — Other Payable: 641000.00
PET.AX balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 127000.00
PET.AX balance_sheet (annual, 2022-12-31) — Payables: 2104000.00
PET.AX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 2104000.00
PET.AX cash_flow (annual, 2022-12-31) — Paymentsto Suppliersfor Goodsand Services: -13507000.00
PET.AX balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 208000.00
PET.AX balance_sheet (annual, 2022-12-31) — Prepaid Assets: 289000.00
PET.AX income_statement (annual, 2022-12-31) — Pretax Income: -11212000.00
PET.AX income_statement (annual, 2022-12-31) — Provision For Doubtful Accounts: -94000.00
PET.AX cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -83000.00
PET.AX cash_flow (annual, 2022-12-31) — Purchase Of PPE: -545000.00
PET.AX balance_sheet (annual, 2022-12-31) — Raw Materials: 873000.00
PET.AX cash_flow (annual, 2022-12-31) — Receiptsfrom Customers: 5555000.00
PET.AX balance_sheet (annual, 2022-12-31) — Receivables: 681000.00
PET.AX balance_sheet (annual, 2022-12-31) — Receivables Adjustments Allowances: -7816000.00
PET.AX income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 2326000.00
PET.AX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 70000.00
PET.AX income_statement (annual, 2022-12-31) — Rent And Landing Fees: 332000.00
PET.AX balance_sheet (annual, 2022-12-31) — Retained Earnings: -78885000.00
PET.AX income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 358000.00
PET.AX income_statement (annual, 2022-12-31) — Selling General And Administration: 6176000.00
PET.AX balance_sheet (annual, 2022-12-31) — Share Issued: 624390509.00
PET.AX income_statement (annual, 2022-12-31) — Special Income Charges: -1513000.00
PET.AX balance_sheet (annual, 2022-12-31) — Stockholders Equity: 14641000.00
PET.AX balance_sheet (annual, 2022-12-31) — Tangible Book Value: 14641000.00
PET.AX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
PET.AX income_statement (annual, 2022-12-31) — Tax Provision: 0.00
PET.AX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
PET.AX balance_sheet (annual, 2022-12-31) — Total Assets: 18117000.00
PET.AX balance_sheet (annual, 2022-12-31) — Total Capitalization: 14641000.00
PET.AX balance_sheet (annual, 2022-12-31) — Total Debt: 955000.00
PET.AX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 14641000.00
PET.AX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 3476000.00
PET.AX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 0.00
PET.AX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 671000.00
PET.AX income_statement (annual, 2022-12-31) — Total Other Finance Cost: 10000.00
PET.AX income_statement (annual, 2022-12-31) — Total Unusual Items: -1513000.00
PET.AX income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -1513000.00
PET.AX balance_sheet (annual, 2022-12-31) — Working Capital: 15312000.00
PET.AX income_statement (annual, 2023-12-31) — +Operating Expense: 4297000.00
PET.AX income_statement (annual, 2023-12-31) — +Total Revenue: 3497000.00
PET.AX balance_sheet (annual, 2023-12-31) — Accounts Payable: 517000.00
PET.AX balance_sheet (annual, 2023-12-31) — Accounts Receivable: 1543000.00
PET.AX income_statement (annual, 2023-12-31) — Amortization: 20000.00
PET.AX income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 20000.00
PET.AX income_statement (annual, 2023-12-31) — Basic Average Shares: 624390509.00
PET.AX income_statement (annual, 2023-12-31) — Basic EPS: 0.00
PET.AX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 14456000.00
PET.AX cash_flow (annual, 2023-12-31) — Capital Expenditure: -533000.00
PET.AX balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 342000.00
PET.AX balance_sheet (annual, 2023-12-31) — Capital Stock: 92398000.00
PET.AX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 10622000.00
PET.AX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 10722000.00
PET.AX balance_sheet (annual, 2023-12-31) — Cash Financial: 10622000.00
PET.AX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -561000.00
PET.AX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -533000.00
PET.AX cash_flow (annual, 2023-12-31) — Cash Flowsfromusedin Operating Activities Direct: -2624000.00
PET.AX cash_flow (annual, 2023-12-31) — Changes In Cash: -3718000.00
PET.AX cash_flow (annual, 2023-12-31) — Classesof Cash Payments: -11419000.00
PET.AX cash_flow (annual, 2023-12-31) — Classesof Cash Receiptsfrom Operating Activities: 8642000.00
PET.AX balance_sheet (annual, 2023-12-31) — Common Stock: 92398000.00
PET.AX balance_sheet (annual, 2023-12-31) — Common Stock Equity: 12236000.00
PET.AX income_statement (annual, 2023-12-31) — Cost Of Revenue: 1575000.00
PET.AX balance_sheet (annual, 2023-12-31) — Current Assets: 14441000.00
PET.AX balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 342000.00
PET.AX balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 342000.00
PET.AX balance_sheet (annual, 2023-12-31) — Current Liabilities: 2167000.00
PET.AX balance_sheet (annual, 2023-12-31) — Current Provisions: 186000.00
PET.AX income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 102000.00
PET.AX income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 102000.00
PET.AX income_statement (annual, 2023-12-31) — Depreciation Income Statement: 82000.00
PET.AX income_statement (annual, 2023-12-31) — Diluted Average Shares: 624390509.00
PET.AX income_statement (annual, 2023-12-31) — Diluted EPS: 0.00
PET.AX income_statement (annual, 2023-12-31) — EBIT: -2375000.00
PET.AX income_statement (annual, 2023-12-31) — EBITDA: -2273000.00
PET.AX cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -116000.00
PET.AX balance_sheet (annual, 2023-12-31) — Employee Benefits: 38000.00
PET.AX cash_flow (annual, 2023-12-31) — End Cash Position: 10622000.00
PET.AX cash_flow (annual, 2023-12-31) — Financing Cash Flow: -561000.00
PET.AX balance_sheet (annual, 2023-12-31) — Finished Goods: 2956000.00
PET.AX balance_sheet (annual, 2023-12-31) — Foreign Currency Translation Adjustments: 779000.00
PET.AX cash_flow (annual, 2023-12-31) — Free Cash Flow: -3157000.00
PET.AX balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 779000.00
PET.AX income_statement (annual, 2023-12-31) — General And Administrative Expense: 5832000.00
PET.AX income_statement (annual, 2023-12-31) — Gross Profit: 1922000.00
PET.AX income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 201000.00
PET.AX income_statement (annual, 2023-12-31) — Interest Income: 163000.00
PET.AX income_statement (annual, 2023-12-31) — Interest Income Non Operating: 163000.00
PET.AX cash_flow (annual, 2023-12-31) — Interest Received Direct: 153000.00
PET.AX balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -2027000.00
PET.AX balance_sheet (annual, 2023-12-31) — Inventory: 1769000.00
PET.AX balance_sheet (annual, 2023-12-31) — Invested Capital: 12236000.00
PET.AX cash_flow (annual, 2023-12-31) — Investing Cash Flow: -533000.00
PET.AX income_statement (annual, 2023-12-31) — Net Income: -2056000.00
PET.AX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -2056000.00
PET.AX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -2056000.00
PET.AX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -2056000.00
PET.AX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -2056000.00
PET.AX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -2056000.00
PET.AX cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -93000.00
PET.AX income_statement (annual, 2023-12-31) — Net Interest Income: 138000.00
PET.AX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 138000.00
PET.AX cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -561000.00
PET.AX cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -440000.00
PET.AX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 12236000.00
PET.AX balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 38000.00
PET.AX income_statement (annual, 2023-12-31) — Normalized EBITDA: -2072000.00
PET.AX income_statement (annual, 2023-12-31) — Normalized Income: -1855000.00
PET.AX income_statement (annual, 2023-12-31) — Operating Income: -2375000.00
PET.AX income_statement (annual, 2023-12-31) — Operating Revenue: 3497000.00
PET.AX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 624390509.00
PET.AX cash_flow (annual, 2023-12-31) — Other Cash Receiptsfrom Operating Activities: 140000.00
PET.AX balance_sheet (annual, 2023-12-31) — Other Current Assets: 419000.00
PET.AX balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 9000.00
PET.AX income_statement (annual, 2023-12-31) — Other Gand A: 5752000.00
PET.AX income_statement (annual, 2023-12-31) — Other Income Expense: -61000.00
PET.AX income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 140000.00
PET.AX income_statement (annual, 2023-12-31) — Other Operating Expenses: 4141000.00
PET.AX balance_sheet (annual, 2023-12-31) — Other Payable: 673000.00
PET.AX balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 100000.00
PET.AX balance_sheet (annual, 2023-12-31) — Payables: 1190000.00
PET.AX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 1190000.00
PET.AX cash_flow (annual, 2023-12-31) — Paymentsto Suppliersfor Goodsand Services: -11419000.00
PET.AX balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 440000.00
PET.AX income_statement (annual, 2023-12-31) — Pretax Income: -2056000.00
PET.AX income_statement (annual, 2023-12-31) — Provision For Doubtful Accounts: -6089000.00
PET.AX cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -93000.00
PET.AX cash_flow (annual, 2023-12-31) — Purchase Of PPE: -440000.00
PET.AX balance_sheet (annual, 2023-12-31) — Raw Materials: 840000.00
PET.AX cash_flow (annual, 2023-12-31) — Receiptsfrom Customers: 8502000.00
PET.AX balance_sheet (annual, 2023-12-31) — Receivables: 1531000.00
PET.AX balance_sheet (annual, 2023-12-31) — Receivables Adjustments Allowances: -12000.00
PET.AX income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1575000.00
PET.AX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 102000.00
PET.AX income_statement (annual, 2023-12-31) — Rent And Landing Fees: 80000.00
PET.AX balance_sheet (annual, 2023-12-31) — Retained Earnings: -80941000.00
PET.AX income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 311000.00
PET.AX income_statement (annual, 2023-12-31) — Selling General And Administration: 6143000.00
PET.AX balance_sheet (annual, 2023-12-31) — Share Issued: 624390509.00
PET.AX income_statement (annual, 2023-12-31) — Special Income Charges: -201000.00
PET.AX balance_sheet (annual, 2023-12-31) — Stockholders Equity: 12236000.00
PET.AX balance_sheet (annual, 2023-12-31) — Tangible Book Value: 12236000.00
PET.AX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
PET.AX income_statement (annual, 2023-12-31) — Tax Provision: 0.00
PET.AX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
PET.AX balance_sheet (annual, 2023-12-31) — Total Assets: 14441000.00
PET.AX balance_sheet (annual, 2023-12-31) — Total Capitalization: 12236000.00
PET.AX balance_sheet (annual, 2023-12-31) — Total Debt: 342000.00
PET.AX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 12236000.00
PET.AX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 2205000.00
PET.AX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 0.00
PET.AX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 38000.00
PET.AX income_statement (annual, 2023-12-31) — Total Other Finance Cost: 25000.00
PET.AX income_statement (annual, 2023-12-31) — Total Unusual Items: -201000.00
PET.AX income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -201000.00
PET.AX balance_sheet (annual, 2023-12-31) — Working Capital: 12274000.00
PET.AX income_statement (annual, 2024-12-31) — +Operating Expense: 3544000.00
PET.AX income_statement (annual, 2024-12-31) — +Total Revenue: 757000.00
PET.AX balance_sheet (annual, 2024-12-31) — Accounts Payable: 240000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 240000.00
PET.AX balance_sheet (annual, 2024-12-31) — Accounts Receivable: 290000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 290000.00
PET.AX income_statement (annual, 2024-12-31) — Amortization: 21000.00
PET.AX income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 21000.00
PET.AX income_statement (annual, 2024-12-31) — Basic Average Shares: 624390509.00
PET.AX income_statement (annual, 2024-12-31) — Basic EPS: 0.00
PET.AX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 10622000.00
PET.AX cash_flow (annual, 2024-12-31) — Capital Expenditure: -49000.00
PET.AX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 367000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 367000.00
PET.AX balance_sheet (annual, 2024-12-31) — Capital Stock: 92398000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Capital Stock: 92398000.00
PET.AX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 7859000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 7859000.00
PET.AX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 7959000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 7959000.00
PET.AX balance_sheet (annual, 2024-12-31) — Cash Financial: 7859000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Cash Financial: 7859000.00
PET.AX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -355000.00
PET.AX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -49000.00
PET.AX cash_flow (annual, 2024-12-31) — Cash Flowsfromusedin Operating Activities Direct: -2851000.00
PET.AX cash_flow (annual, 2024-12-31) — Changes In Cash: -3255000.00
PET.AX cash_flow (annual, 2024-12-31) — Classesof Cash Payments: -5019000.00
PET.AX cash_flow (annual, 2024-12-31) — Classesof Cash Receiptsfrom Operating Activities: 2079000.00
PET.AX balance_sheet (annual, 2024-12-31) — Common Stock: 92398000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Common Stock: 92398000.00
PET.AX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 10007000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 10007000.00
PET.AX income_statement (annual, 2024-12-31) — Cost Of Revenue: 706000.00
PET.AX balance_sheet (annual, 2024-12-31) — Current Assets: 11233000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Current Assets: 11233000.00
PET.AX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 16000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 16000.00
PET.AX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 16000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 16000.00
PET.AX balance_sheet (annual, 2024-12-31) — Current Liabilities: 864000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 864000.00
PET.AX income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 21000.00
PET.AX income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 21000.00
PET.AX income_statement (annual, 2024-12-31) — Diluted Average Shares: 624390509.00
PET.AX income_statement (annual, 2024-12-31) — Diluted EPS: 0.00
PET.AX income_statement (annual, 2024-12-31) — EBIT: -3493000.00
PET.AX income_statement (annual, 2024-12-31) — EBITDA: -3472000.00
PET.AX cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 492000.00
PET.AX balance_sheet (annual, 2024-12-31) — Employee Benefits: 11000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Employee Benefits: 11000.00
PET.AX cash_flow (annual, 2024-12-31) — End Cash Position: 7859000.00
PET.AX cash_flow (annual, 2024-12-31) — Financing Cash Flow: -355000.00
PET.AX balance_sheet (annual, 2024-12-31) — Finished Goods: 2791000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Finished Goods: 2791000.00
PET.AX balance_sheet (annual, 2024-12-31) — Foreign Currency Translation Adjustments: 827000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Foreign Currency Translation Adjustments: 827000.00
PET.AX cash_flow (annual, 2024-12-31) — Free Cash Flow: -2900000.00
PET.AX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 827000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 827000.00
PET.AX income_statement (annual, 2024-12-31) — General And Administrative Expense: 1852000.00
PET.AX income_statement (annual, 2024-12-31) — Gross Profit: 51000.00
PET.AX income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: -568000.00
PET.AX income_statement (annual, 2024-12-31) — Interest Income: 89000.00
PET.AX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 89000.00
PET.AX cash_flow (annual, 2024-12-31) — Interest Received Direct: 89000.00
PET.AX balance_sheet (annual, 2024-12-31) — Inventories Adjustments Allowances: -1186000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Inventories Adjustments Allowances: -1186000.00
PET.AX balance_sheet (annual, 2024-12-31) — Inventory: 2497000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Inventory: 2497000.00
PET.AX balance_sheet (annual, 2024-12-31) — Invested Capital: 10007000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Invested Capital: 10007000.00
PET.AX cash_flow (annual, 2024-12-31) — Investing Cash Flow: -49000.00
PET.AX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 351000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 351000.00
PET.AX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 351000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 351000.00
PET.AX income_statement (annual, 2024-12-31) — Net Income: -2277000.00
PET.AX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -2277000.00
PET.AX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -2277000.00
PET.AX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -2277000.00
PET.AX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -2277000.00
PET.AX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -2277000.00
PET.AX cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -17000.00
PET.AX income_statement (annual, 2024-12-31) — Net Interest Income: 74000.00
PET.AX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 74000.00
PET.AX cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -355000.00
PET.AX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -32000.00
PET.AX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 10007000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 10007000.00
PET.AX balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 11000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 11000.00
PET.AX income_statement (annual, 2024-12-31) — Normalized EBITDA: -4040000.00
PET.AX income_statement (annual, 2024-12-31) — Normalized Income: -2845000.00
PET.AX income_statement (annual, 2024-12-31) — Operating Income: -3493000.00
PET.AX income_statement (annual, 2024-12-31) — Operating Revenue: 757000.00
PET.AX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 624390509.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 624390509.00
PET.AX balance_sheet (annual, 2024-12-31) — Other Current Assets: 403000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 403000.00
PET.AX balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 2000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 2000.00
PET.AX income_statement (annual, 2024-12-31) — Other Gand A: 1845000.00
PET.AX income_statement (annual, 2024-12-31) — Other Income Expense: 1121000.00
PET.AX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 553000.00
PET.AX income_statement (annual, 2024-12-31) — Other Operating Expenses: 1533000.00
PET.AX balance_sheet (annual, 2024-12-31) — Other Payable: 544000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Other Payable: 544000.00
PET.AX balance_sheet (annual, 2024-12-31) — Other Receivables: 97000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Other Receivables: 97000.00
PET.AX balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 100000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 100000.00
PET.AX balance_sheet (annual, 2024-12-31) — Payables: 784000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Payables: 784000.00
PET.AX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 784000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 784000.00
PET.AX cash_flow (annual, 2024-12-31) — Paymentsto Suppliersfor Goodsand Services: -5019000.00
PET.AX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 62000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 62000.00
PET.AX income_statement (annual, 2024-12-31) — Pretax Income: -2277000.00
PET.AX cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -17000.00
PET.AX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -32000.00
PET.AX balance_sheet (annual, 2024-12-31) — Raw Materials: 892000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Raw Materials: 892000.00
PET.AX cash_flow (annual, 2024-12-31) — Receiptsfrom Customers: 2079000.00
PET.AX balance_sheet (annual, 2024-12-31) — Receivables: 374000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Receivables: 374000.00
PET.AX balance_sheet (annual, 2024-12-31) — Receivables Adjustments Allowances: -13000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Receivables Adjustments Allowances: -13000.00
PET.AX income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 706000.00
PET.AX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 21000.00
PET.AX income_statement (annual, 2024-12-31) — Rent And Landing Fees: 7000.00
PET.AX balance_sheet (annual, 2024-12-31) — Retained Earnings: -83218000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -83218000.00
PET.AX income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 138000.00
PET.AX income_statement (annual, 2024-12-31) — Selling General And Administration: 1990000.00
PET.AX balance_sheet (annual, 2024-12-31) — Share Issued: 624390509.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Share Issued: 624390509.00
PET.AX income_statement (annual, 2024-12-31) — Special Income Charges: 568000.00
PET.AX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 10007000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 10007000.00
PET.AX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 10007000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 10007000.00
PET.AX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
PET.AX income_statement (annual, 2024-12-31) — Tax Provision: 0.00
PET.AX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
PET.AX balance_sheet (annual, 2024-12-31) — Total Assets: 11233000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Total Assets: 11233000.00
PET.AX balance_sheet (annual, 2024-12-31) — Total Capitalization: 10007000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 10007000.00
PET.AX balance_sheet (annual, 2024-12-31) — Total Debt: 367000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Total Debt: 367000.00
PET.AX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 10007000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 10007000.00
PET.AX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1226000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 1226000.00
PET.AX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 0.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 0.00
PET.AX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 362000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 362000.00
PET.AX income_statement (annual, 2024-12-31) — Total Other Finance Cost: 15000.00
PET.AX income_statement (annual, 2024-12-31) — Total Unusual Items: 568000.00
PET.AX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 568000.00
PET.AX balance_sheet (annual, 2024-12-31) — Working Capital: 10369000.00
PET.AX balance_sheet (quarterly, 2024-12-31) — Working Capital: 10369000.00
PET.AX income_statement (annual, 2025-12-31) — +Operating Expense: 4939000.00
PET.AX income_statement (annual, 2025-12-31) — +Total Revenue: 3095000.00
PET.AX balance_sheet (annual, 2025-12-31) — Accounts Payable: 445000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 445000.00
PET.AX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 342000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 342000.00
PET.AX income_statement (annual, 2025-12-31) — Basic Average Shares: 624390509.00
PET.AX income_statement (annual, 2025-12-31) — Basic EPS: -0.01
PET.AX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 7859000.00
PET.AX cash_flow (annual, 2025-12-31) — Capital Expenditure: -120000.00
PET.AX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 689000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 689000.00
PET.AX balance_sheet (annual, 2025-12-31) — Capital Stock: 92398000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 92398000.00
PET.AX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 5205000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 5205000.00
PET.AX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5305000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5305000.00
PET.AX balance_sheet (annual, 2025-12-31) — Cash Financial: 5205000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Cash Financial: 5205000.00
PET.AX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -436000.00
PET.AX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -120000.00
PET.AX cash_flow (annual, 2025-12-31) — Cash Flowsfromusedin Operating Activities Direct: -1811000.00
PET.AX cash_flow (annual, 2025-12-31) — Changes In Cash: -2367000.00
PET.AX cash_flow (annual, 2025-12-31) — Classesof Cash Payments: -4970000.00
PET.AX cash_flow (annual, 2025-12-31) — Classesof Cash Receiptsfrom Operating Activities: 3134000.00
PET.AX balance_sheet (annual, 2025-12-31) — Common Stock: 92398000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Common Stock: 92398000.00
PET.AX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 6819000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 6819000.00
PET.AX income_statement (annual, 2025-12-31) — Cost Of Revenue: 1127000.00
PET.AX balance_sheet (annual, 2025-12-31) — Current Assets: 8438000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Current Assets: 8438000.00
PET.AX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 475000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 475000.00
PET.AX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 475000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 475000.00
PET.AX balance_sheet (annual, 2025-12-31) — Current Liabilities: 1387000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1387000.00
PET.AX income_statement (annual, 2025-12-31) — Diluted Average Shares: 624390509.00
PET.AX income_statement (annual, 2025-12-31) — Diluted EPS: -0.01
PET.AX income_statement (annual, 2025-12-31) — EBIT: -2971000.00
PET.AX income_statement (annual, 2025-12-31) — EBITDA: -2971000.00
PET.AX cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -287000.00
PET.AX balance_sheet (annual, 2025-12-31) — Employee Benefits: 18000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 18000.00
PET.AX cash_flow (annual, 2025-12-31) — End Cash Position: 5205000.00
PET.AX cash_flow (annual, 2025-12-31) — Financing Cash Flow: -436000.00
PET.AX balance_sheet (annual, 2025-12-31) — Finished Goods: 1871000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Finished Goods: 1871000.00
PET.AX balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: 892000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: 892000.00
PET.AX cash_flow (annual, 2025-12-31) — Free Cash Flow: -1931000.00
PET.AX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 892000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 892000.00
PET.AX income_statement (annual, 2025-12-31) — General And Administrative Expense: 2335000.00
PET.AX income_statement (annual, 2025-12-31) — Gross Profit: 1968000.00
PET.AX income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 829000.00
PET.AX income_statement (annual, 2025-12-31) — Interest Income: 24000.00
PET.AX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 24000.00
PET.AX cash_flow (annual, 2025-12-31) — Interest Received Direct: 25000.00
PET.AX balance_sheet (annual, 2025-12-31) — Inventories Adjustments Allowances: -363000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Inventories Adjustments Allowances: -363000.00
PET.AX balance_sheet (annual, 2025-12-31) — Inventory: 2379000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Inventory: 2379000.00
PET.AX balance_sheet (annual, 2025-12-31) — Invested Capital: 6819000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 6819000.00
PET.AX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -120000.00
PET.AX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 214000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 214000.00
PET.AX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 214000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 214000.00
PET.AX income_statement (annual, 2025-12-31) — Net Income: -3253000.00
PET.AX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -3253000.00
PET.AX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -3253000.00
PET.AX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -3253000.00
PET.AX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -3253000.00
PET.AX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -3253000.00
PET.AX cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -53000.00
PET.AX income_statement (annual, 2025-12-31) — Net Interest Income: 0.00
PET.AX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 0.00
PET.AX cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -436000.00
PET.AX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -67000.00
PET.AX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 6819000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 6819000.00
PET.AX balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 18000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 18000.00
PET.AX income_statement (annual, 2025-12-31) — Normalized EBITDA: -2142000.00
PET.AX income_statement (annual, 2025-12-31) — Normalized Income: -2424000.00
PET.AX income_statement (annual, 2025-12-31) — Operating Income: -2971000.00
PET.AX income_statement (annual, 2025-12-31) — Operating Revenue: 3095000.00
PET.AX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 624390509.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 624390509.00
PET.AX balance_sheet (annual, 2025-12-31) — Other Current Assets: 412000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 412000.00
PET.AX balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 2000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 2000.00
PET.AX income_statement (annual, 2025-12-31) — Other Gand A: 2314000.00
PET.AX income_statement (annual, 2025-12-31) — Other Income Expense: -282000.00
PET.AX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 547000.00
PET.AX income_statement (annual, 2025-12-31) — Other Operating Expenses: 2322000.00
PET.AX balance_sheet (annual, 2025-12-31) — Other Payable: 367000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Other Payable: 367000.00
PET.AX balance_sheet (annual, 2025-12-31) — Other Receivables: 13000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Other Receivables: 13000.00
PET.AX balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 100000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 100000.00
PET.AX balance_sheet (annual, 2025-12-31) — Payables: 812000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Payables: 812000.00
PET.AX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 812000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 812000.00
PET.AX cash_flow (annual, 2025-12-31) — Paymentsto Suppliersfor Goodsand Services: -4970000.00
PET.AX balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 98000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 98000.00
PET.AX income_statement (annual, 2025-12-31) — Pretax Income: -3253000.00
PET.AX cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -53000.00
PET.AX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -67000.00
PET.AX balance_sheet (annual, 2025-12-31) — Raw Materials: 871000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Raw Materials: 871000.00
PET.AX cash_flow (annual, 2025-12-31) — Receiptsfrom Customers: 3134000.00
PET.AX balance_sheet (annual, 2025-12-31) — Receivables: 342000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Receivables: 342000.00
PET.AX balance_sheet (annual, 2025-12-31) — Receivables Adjustments Allowances: -13000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Receivables Adjustments Allowances: -13000.00
PET.AX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1127000.00
PET.AX income_statement (annual, 2025-12-31) — Rent And Landing Fees: 21000.00
PET.AX balance_sheet (annual, 2025-12-31) — Retained Earnings: -86471000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -86471000.00
PET.AX income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 282000.00
PET.AX income_statement (annual, 2025-12-31) — Selling General And Administration: 2617000.00
PET.AX balance_sheet (annual, 2025-12-31) — Share Issued: 624390509.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Share Issued: 624390509.00
PET.AX income_statement (annual, 2025-12-31) — Special Income Charges: -829000.00
PET.AX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 6819000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 6819000.00
PET.AX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 6819000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 6819000.00
PET.AX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
PET.AX income_statement (annual, 2025-12-31) — Tax Provision: 0.00
PET.AX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
PET.AX balance_sheet (annual, 2025-12-31) — Total Assets: 8438000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Total Assets: 8438000.00
PET.AX balance_sheet (annual, 2025-12-31) — Total Capitalization: 6819000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 6819000.00
PET.AX balance_sheet (annual, 2025-12-31) — Total Debt: 689000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Total Debt: 689000.00
PET.AX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 6819000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 6819000.00
PET.AX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1619000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1619000.00
PET.AX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 0.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 0.00
PET.AX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 232000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 232000.00
PET.AX income_statement (annual, 2025-12-31) — Total Other Finance Cost: 24000.00
PET.AX income_statement (annual, 2025-12-31) — Total Unusual Items: -829000.00
PET.AX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -829000.00
PET.AX balance_sheet (annual, 2025-12-31) — Working Capital: 7051000.00
PET.AX balance_sheet (quarterly, 2025-12-31) — Working Capital: 7051000.00
PET.L income_statement (annual, 2021-12-31) — +Operating Expense: 322077.00
PET.L income_statement (annual, 2021-12-31) — +Total Revenue: 0.00
PET.L balance_sheet (annual, 2021-12-31) — Additional Paid In Capital: 21995353.00
PET.L income_statement (annual, 2021-12-31) — Basic Average Shares: 157038467.00
PET.L income_statement (annual, 2021-12-31) — Basic EPS: 0.00
PET.L cash_flow (annual, 2021-12-31) — Beginning Cash Position: 333900.00
PET.L cash_flow (annual, 2021-12-31) — Capital Expenditure: -1200.00
PET.L balance_sheet (annual, 2021-12-31) — Capital Stock: 1962981.00
PET.L balance_sheet (annual, 2021-12-31) — Cash And Cash Equivalents: 101843.00
PET.L balance_sheet (annual, 2021-12-31) — Cash Cash Equivalents And Short Term Investments: 101843.00
PET.L balance_sheet (annual, 2021-12-31) — Cash Financial: 101843.00
PET.L cash_flow (annual, 2021-12-31) — Change In Payable: 81889.00
PET.L cash_flow (annual, 2021-12-31) — Change In Receivables: 9331.00
PET.L cash_flow (annual, 2021-12-31) — Change In Working Capital: 91220.00
PET.L cash_flow (annual, 2021-12-31) — Changes In Cash: -241679.00
PET.L balance_sheet (annual, 2021-12-31) — Common Stock: 1962981.00
PET.L balance_sheet (annual, 2021-12-31) — Common Stock Equity: 268243.00
PET.L cash_flow (annual, 2021-12-31) — Common Stock Issuance: 0.00
PET.L balance_sheet (annual, 2021-12-31) — Current Assets: 127506.00
PET.L balance_sheet (annual, 2021-12-31) — Current Liabilities: 792430.00
PET.L income_statement (annual, 2021-12-31) — Diluted Average Shares: 157038467.00
PET.L income_statement (annual, 2021-12-31) — Diluted EPS: 0.00
PET.L income_statement (annual, 2021-12-31) — Diluted NI Availto Com Stockholders: -322077.00
PET.L income_statement (annual, 2021-12-31) — EBIT: -322077.00
PET.L income_statement (annual, 2021-12-31) — EBITDA: -322077.00
PET.L cash_flow (annual, 2021-12-31) — Effect Of Exchange Rate Changes: 9622.00
PET.L cash_flow (annual, 2021-12-31) — End Cash Position: 101843.00
PET.L cash_flow (annual, 2021-12-31) — Financing Cash Flow: 0.00
PET.L cash_flow (annual, 2021-12-31) — Free Cash Flow: -241679.00
PET.L income_statement (annual, 2021-12-31) — General And Administrative Expense: 232077.00
PET.L balance_sheet (annual, 2021-12-31) — Gross PPE: 933167.00
PET.L income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 0.00
PET.L balance_sheet (annual, 2021-12-31) — Invested Capital: 268243.00
PET.L cash_flow (annual, 2021-12-31) — Investing Cash Flow: -1200.00
PET.L cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 0.00
PET.L cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 0.00
PET.L cash_flow (annual, 2021-12-31) — Net Foreign Currency Exchange Gain Loss: -9622.00
PET.L income_statement (annual, 2021-12-31) — Net Income: -322077.00
PET.L income_statement (annual, 2021-12-31) — Net Income Common Stockholders: -322077.00
PET.L income_statement (annual, 2021-12-31) — Net Income Continuous Operations: -322077.00
PET.L income_statement (annual, 2021-12-31) — Net Income From Continuing And Discontinued Operation: -322077.00
PET.L income_statement (annual, 2021-12-31) — Net Income From Continuing Operation Net Minority Interest: -322077.00
PET.L cash_flow (annual, 2021-12-31) — Net Income From Continuing Operations: -322077.00
PET.L income_statement (annual, 2021-12-31) — Net Income Including Noncontrolling Interests: -322077.00
PET.L balance_sheet (annual, 2021-12-31) — Net PPE: 933167.00
PET.L cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: -1200.00
PET.L balance_sheet (annual, 2021-12-31) — Net Tangible Assets: 268243.00
PET.L income_statement (annual, 2021-12-31) — Normalized EBITDA: -322077.00
PET.L income_statement (annual, 2021-12-31) — Normalized Income: -322077.00
PET.L cash_flow (annual, 2021-12-31) — Operating Cash Flow: -240479.00
PET.L income_statement (annual, 2021-12-31) — Operating Income: -322077.00
PET.L income_statement (annual, 2021-12-31) — Operating Revenue: 0.00
PET.L balance_sheet (annual, 2021-12-31) — Ordinary Shares Number: 157038467.00
PET.L balance_sheet (annual, 2021-12-31) — Other Equity Interest: 26871.00
PET.L balance_sheet (annual, 2021-12-31) — Other Payable: 775930.00
PET.L income_statement (annual, 2021-12-31) — Otherunder Preferred Stock Dividend: 0.00
PET.L balance_sheet (annual, 2021-12-31) — Payables: 775930.00
PET.L balance_sheet (annual, 2021-12-31) — Prepaid Assets: 5889.00
PET.L income_statement (annual, 2021-12-31) — Pretax Income: -322077.00
PET.L balance_sheet (annual, 2021-12-31) — Properties: 933167.00
PET.L cash_flow (annual, 2021-12-31) — Purchase Of PPE: -1200.00
PET.L balance_sheet (annual, 2021-12-31) — Retained Earnings: -23724656.00
PET.L cash_flow (annual, 2021-12-31) — Sale Of PPE: 0.00
PET.L income_statement (annual, 2021-12-31) — Selling General And Administration: 232077.00
PET.L balance_sheet (annual, 2021-12-31) — Share Issued: 157038467.00
PET.L balance_sheet (annual, 2021-12-31) — Stockholders Equity: 268243.00
PET.L balance_sheet (annual, 2021-12-31) — Tangible Book Value: 268243.00
PET.L income_statement (annual, 2021-12-31) — Tax Effect Of Unusual Items: 0.00
PET.L income_statement (annual, 2021-12-31) — Tax Provision: 0.00